Merger (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 15, 2022	Dec. 31, 2022	Dec. 31, 2021
Asset Acquisition [Line Items]
Total purchase price	$ 36,100
Common stock, shares, outstanding (shares)		7,866,061	3,985,981
CEND
Asset Acquisition [Line Items]
Total purchase price	$ 36,098
Common stock, shares, outstanding (shares)	3,772,768
Multiplied by the fair value per share of Lisata common stock on September 15, 2022	$ 6.25
Total	$ 23,580
Carrying value of Lisata's cost method investment in Cend	10,000
Incremental fair value of Cend's fully vested stock options	2,136
Lisata transaction costs	382
Cash and cash equivalents	7,062
Net working capital (excluding cash)	(1,690)
Other liabilities	(22)
Acquired in-process research and development	30,393
License	$ 355